The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Screening for Prostate Cancer
Abstract
Epidemiologically, screening is justified by the importance of the disease and the lack of prospects for primary prevention, but evidence from natural history is unhelpful since men are more likely to die with, rather than from, prostate cancer. The available screening tests do not always detect men whose lesions could result in future morbidity or mortality. Evidence is limited for the benefits of treatment for localised cancers detected through screening, whereas the evidence for harm is clear. Observational evidence for the effect of population screening programmes is mixed, with no clear association between intensity of screening and reduced prostate cancer mortality. Screening for prostate cancer cannot be justified in low-risk populations, but the balance of benefit and harm will be more favourable after risk stratification. Prostate cancer screening can be justified only in research programmes designed to assess its effectiveness and help identify the groups who may benefit.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ankerst, D. P., Hoefler, J., Bock, S., Goodman, P. J., Vickers, A., Hernandez, J., Sokoll, L. J., Sanda, M. G., Wei, J. T., Leach, R. J., et al. (2014) · Urology · doi:10.1016/j.urology.2014.02.035 · Cited by 236
Who benefits from medical interventions?
Smith, G. D., & Egger, M. (1994) · BMJ · doi:10.1136/bmj.308.6921.72 · Cited by 128
Cited by
Recurrent gene fusions in prostate cancer
Kumar-Sinha, C., Tomlins, S. A., & Chinnaiyan, A. M. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2402 · Cited by 664
International epidemiology of prostate cancer: Geographical distribution and secular trends
Baade, P. D., Youlden, D. R., & Krnjacki, L. J. (2009) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200700511 · Cited by 444
Risk factors for the onset of prostatic cancer: age, location, and behavioral correlates
Leitzmann, M., & Rohrmann, S. (2012) · Clinical Epidemiology · doi:10.2147/clep.s16747 · Cited by 304
Fan, Y., Murphy, T. B., Byrne, J. C., Brennan, L., Fitzpatrick, J. M., & Watson, R. W. G. (2011) · Journal of Proteome Research · doi:10.1021/pr1011069 · Cited by 77
de Salis, I., Tomlin, Z., Toerien, M., & Donovan, J. (2008) · Journal of Health Services Research & Policy · doi:10.1258/jhsrp.2008.008028 · Cited by 49
Metadata
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2023-07-06
- Volume
- 389
- Issue
- 1
- Pages
- 92-94
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2123002328
- Cited by
- 178
- References
- 2
- FWCI
- 1.11
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Screening for Prostate Cancer. https://app.cochat.ai/papers/10.1056/nejmc2305651
- The paper
- Screening for Prostate Cancer. (2023). New England Journal of Medicine. https://doi.org/10.1056/nejmc2305651
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.